The weekly federal-spending brief. One email a Sunday. Free. No tracking.
The BuildoutBeta

$1,775,380,496

Department of Health and Human Services·National Institutes of Health

to LEIDOS BIOMEDICAL RESEARCH INC

healthexpiredONGOING · MOD OF 2020 CONTRACT
WORK BEGAN2020-08-31·LATEST ACTION2026-06-18·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75N91020F00003_7529_75N91019D00024_7529
Award description

NCI OPERATIONAL TASK ORDER

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high
In plain English

Modification to the NCI operations contract begun in 2020, supporting the nation's cancer research and prevention efforts.

Sub-sectors
nih-operationscancer-research-supportm&o-contract
Why this matters

This multi-billion-dollar operations contract sustains the National Cancer Institute, central to U.S. cancer research leadership and public health.

Supply-chain signal

Leidos provides operational support; NCI funding flows to university and hospital research partners nationwide.

U.S.–China competition angle

Secures U.S. leadership in cancer research amid growing international biomedical R&D competition including China's investments.

Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-06-20. Cost: $0.026413.

Period of performance
Start
2020-08-31
End
2024-09-27
Status
expired631 days ago
Sources

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.